BioNTech SE (BNTX) income statement
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$80.96−0.42 (-0.52%)
Close on Nov 20, 2026Market cap $20.34BP/E –Yield –
BioNTech SE financial ratios
See a number that looks wrong?